{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:11:13Z","timestamp":1788883873034,"version":"build-2803163510"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"DOI":"10.1038\/s41366-026-02215-y","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:20:16Z","timestamp":1788841216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Where does surgery fit in the era of effective obesity pharmacotherapy? Positioning metabolic bariatric surgery within multimodal obesity care"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8779-3055","authenticated-orcid":false,"given":"Ricardo V.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6435-9264","authenticated-orcid":false,"given":"Paulina","family":"Salminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Prager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"2215_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13:221\u201362. https:\/\/doi.org\/10.1016\/S2213-8587(24)00316-4.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2215_CR2","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(22)02403-5","volume":"401","author":"CM Perdomo","year":"2023","unstructured":"Perdomo CM, Cohen RV, Sumithran P, Cl\u00e9ment K, Fr\u00fchbeck G. Contemporary medical, device, and surgical therapies for obesity in adults. Lancet. 2023;401:1116\u201330. https:\/\/doi.org\/10.1016\/S0140-6736(22)02403-5.","journal-title":"Lancet"},{"issue":"10456","key":"2215_CR3","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/S0140-6736(24)01210-8","volume":"404","author":"I Lingvay","year":"2024","unstructured":"Lingvay I, Cohen RV, le Roux CW, Sumithran P. Obesity in adults. Lancet. 2024;404(10456):972\u201387. https:\/\/doi.org\/10.1016\/S0140-6736(24)01210-8.","journal-title":"Lancet"},{"key":"2215_CR4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41366-025-01967-3","volume":"50","author":"A Lautenbach","year":"2026","unstructured":"Lautenbach A, Bl\u00fcher M, Mijuskovic A, Jones L, Schirmann F. Efficacy of a digital health application for weight management in people with obesity: 6-months results from a randomized controlled trial. Int J Obes (Lond). 2026;50:466\u201373.","journal-title":"Int J Obes (Lond)"},{"key":"2215_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11695-022-06332-1","volume":"33","author":"D Eisenberg","year":"2023","unstructured":"Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Obes Surg. 2023;33:3\u201314. https:\/\/doi.org\/10.1007\/s11695-022-06332-1.","journal-title":"Obes Surg"},{"key":"2215_CR6","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S2213-8587(25)00198-6","volume":"13","author":"RV Cohen","year":"2025","unstructured":"Cohen RV, Prager G, le Roux CW, Lingvay I, Salminen P. International Federation for the Surgery of Obesity statement on metabolic bariatric surgery after pharmacotherapy-induced weight loss in clinical obesity. Lancet Diabetes Endocrinol. 2025;13:733\u20136. https:\/\/doi.org\/10.1016\/S2213-8587(25)00198-6.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"2215_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.soard.2025.04.004","volume":"21","author":"SJ Lloyd","year":"2025","unstructured":"Lloyd SJ, Wall-Wieler E, Liu Y, Zheng F, LaMasters T. Unveiling the cost-effectiveness of bariatric surgery: insights from a matched cohort study. Surg Obes Relat Dis. 2025;21(9):987\u201395. https:\/\/doi.org\/10.1016\/j.soard.2025.04.004.","journal-title":"Surg Obes Relat Dis"},{"issue":"11","key":"2215_CR8","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.1007\/s00464-024-11191-1","volume":"38","author":"S Docimo Jr","year":"2024","unstructured":"Docimo S Jr, Shah J, Warren G, Ganam S, Sujka J, et al. A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point? Surg Endosc. 2024;38(11):6560\u20135. https:\/\/doi.org\/10.1007\/s00464-024-11191-1.","journal-title":"Surg Endosc"},{"issue":"1","key":"2215_CR9","doi-asserted-by":"publisher","first-page":"e2457349","DOI":"10.1001\/jamanetworkopen.2024.57349","volume":"8","author":"PJ Rodriguez","year":"2025","unstructured":"Rodriguez PJ, Zhang V, Gratzl S, Do D, Cartwright JB, Baker C, et al. Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity. JAMA Netw Open. 2025;8(1):e2457349 https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.57349.","journal-title":"JAMA Netw Open"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02215-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02215-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02215-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:02:55Z","timestamp":1788883375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02215-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":9,"alternative-id":["2215"],"URL":"https:\/\/doi.org\/10.1038\/s41366-026-02215-y","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RVC received research grants from Johnson & Johnson and Medtronic (paid to institution); consulting fees from Regeneron; Scientific Advisory Board for JJ Medtech,Morphic Medical, NovoNordisk; Paid lectures from Eli Lilly, Currax, NovoNordisk, JJ Medtech and is the Immediate Past President of the International Federation for the Surgery and Other Therapies for Obesity (IFSO). PS received grants from the Sigrid Jus\u00e9lius Foundation, Academy of Finland, and European Research Council; honoraria from Novo Nordisk; participated on a data safety monitoring board for GM Solutions; is the President of the IFSO European Chapter. JP received honoraria from Johnson &Johnson,Medtronic, Allurion Technologies and GT Metabolic and is IFSO President-Elect. GP received consulting fees from Medtronic, Johnson & Johnson, Novo Nordisk, and Eli Lilly; honoraria from Medtronic and Olympus; and is IFSO Senior Past President.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}